Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

DEXA Bone Density Analysis of the CoreHip® Prosthesis System

NCT: NCT06632301 · NOT_YET_RECRUITING

NCT IDNCT06632301
StatusNOT_YET_RECRUITING
Start Date2026-12
Completion2028-09
SponsorAesculap AG (INDUSTRY)
First posted
Last updated

Brief Summary

The goal of this interventional post-market follow-up study is to evaluate radiological changes in the diaphyseal bone density (Gruen Zones 3 and 4) within 24 months postoperative in patients treated with CoreHip® primary cementless stem. The DEXA bone density analysis is used.

Frequently Asked Questions

What is DEXA Bone Density Analysis of the CoreHip® Prosthesis System?

DEXA Bone Density Analysis of the CoreHip® Prosthesis System is a clinical trial registered under NCT06632301. Current status: NOT_YET_RECRUITING.

What is the status of NCT06632301?

The current status of NCT06632301 (DEXA Bone Density Analysis of the CoreHip® Prosthesis System) is: NOT_YET_RECRUITING.

When did DEXA Bone Density Analysis of the CoreHip® Prosthesis System start?

DEXA Bone Density Analysis of the CoreHip® Prosthesis System started on 2026-12.

Related Devices

K151165Aesculap Dafilon Nonabsorbable Polyamide Surgical SutureAesculap, Inc. K152960ELAN 4 Motor SystemAesculap, Inc. K160393AdTecAesculap, Inc. K161853proGAV Programmable Shunt System, proGAV 2.0 Adjustable Shunt System, proSA Adjustable Shunt SystemAesculap, Inc. K162815SterilContainer S SystemAesculap, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑